J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate03-02-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificateJ.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Update on Acquisition of Brands and Related Assets from Sanzyme Private LimitedJ.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Investors/analysts call Transcript and Audio recordingEarnings Call for Q3FY22 of J B Chemicals & Pharmaceuticals
Conference Call with J B Chemicals & Pharmaceuticals Ltd. Management and Analysts on new acquisitions. Listen to the full transcript.J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Investor Presentation -in relation to the Acquisition of Brands and Related Assets from Sanzyme Private Limited.J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company has scheduled a conference call for investors and analysts on Thursday, January 27, 2022 at 3.30 p.m. IST to discuss the Acquisition of Brands and Related Assets from Sanzyme Private Limited.J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of a portfolio of brands, for use and commercialization within India, from Sanzyme Private LimitedJ.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Change in Directorate
Resignation of DirectorJ.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Shareholding for the Period Ended December 31, 2021
JB Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here